Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Vivitrol dosing and administration
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis.
Laquinimod Halted MS Disability But Not Relapses
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Recommendations for diagnosis and management of multiple sclerosis.
Gray matter is targeted in first-attack multiple sclerosis.
Myelination of the nervous system: mechanisms and functions.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.

Pages